Covered recipient · General Payments record
DARLA R MOORE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$708.31
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $260.52 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $164.61 | 13 |
| Alkermes, Inc. | $20.66 | 1 |
| Novo Nordisk AS | $18.33 | 1 |
| Lilly USA, LLC | $16.60 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.07 | 1 |
| Indivior Inc. | $13.17 | 1 |
| Exact Sciences Corporation | $13.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $4.89 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107685349 | CMS |
| ABBVIE INC. | $12.05 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107685351 | CMS |
| ABBVIE INC. | $2.48 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107685353 | CMS |
| ABBVIE INC. | $22.35 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107685355 | CMS |
| ABBVIE INC. | $16.93 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107685357 | CMS |
| ABBVIE INC. | $25.38 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107685359 | CMS |
| ABBVIE INC. | $17.00 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107685361 | CMS |
| ABBVIE INC. | $11.74 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107685363 | CMS |
| ABBVIE INC. | $12.30 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107685365 | CMS |
| ABBVIE INC. | $14.18 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107685367 | CMS |
| ABBVIE INC. | $6.25 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107685369 | CMS |
| ABBVIE INC. | $5.53 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107685371 | CMS |
| ABBVIE INC. | $13.53 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107685373 | CMS |
| Alkermes, Inc. | $20.66 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120557539 | CMS |
| Exact Sciences Corporation | $13.08 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114546996 | CMS |
| Indivior Inc. | $13.17 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144564015 | CMS |
| Lilly USA, LLC | $16.60 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135610509 | CMS |
| Novo Nordisk Inc | $18.33 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100472193 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.07 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151190514 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.